Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ratjen

Showing results (161-170 of 385) with videos related to

Pageof 39
Sort By:
Pediatric Pulmonology|July 14, 2023
Treatment response to pulmonary exacerbation in primary ciliary dyskinesiaDvir Gatt, Michelle Shaw, Valerie Waters, et al.
Academic Radiology|August 9, 2018
Hyperpolarized Gas Magnetic Resonance Imaging of Pediatric Cystic Fibrosis Lung DiseaseGiles Santyr, Nikhil Kanhere, Felipe Morgado, et al.
Plos One|March 6, 2014
Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumoniaAnne Mehl, Peyman Ghorbani, David Douda, et al.
Mediators of Inflammation|September 2, 2014
Multitracer stable isotope quantification of arginase and nitric oxide synthase activity in a mouse model of pseudomonas lung infectionHartmut Grasemann, Thomas Jaecklin, Anne Mehl, et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2004
Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosisMatthias Griese, Robert Essl, Reinhold Schmidt, et al.
Annals of the American Thoracic Society|April 14, 2017
Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic FibrosisRanjani Somayaji, Sanja Stanojevic, D Elizabeth Tullis, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 2, 2025
Biomarkers associated with clinical response to cystic fibrosis pulmonary exacerbation treatment and adjuvant prednisone therapyBradley S Quon, Jasleen K Matta, Michelle Shaw, et al.
Annals of Internal Medicine|July 19, 2021
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic TelangiectasiaMarie E Faughnan, Johannes J Mager, Steven W Hetts, et al.
The European Respiratory Journal|October 12, 2019
Long-term effect of CFTR modulator therapy on airway nitric oxideHartmut Grasemann, Michelle Klingel, Julie Avolio, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 22, 2022
Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosisIsabel Gascon Casaredi, Michelle Shaw, Valerie Waters, et al.
Pageof 39

Showing results (161-170 of 385) with videos related to

Sort By:
Pageof 39
Pediatric Pulmonology|July 14, 2023
Treatment response to pulmonary exacerbation in primary ciliary dyskinesiaDvir Gatt, Michelle Shaw, Valerie Waters, et al.
Academic Radiology|August 9, 2018
Hyperpolarized Gas Magnetic Resonance Imaging of Pediatric Cystic Fibrosis Lung DiseaseGiles Santyr, Nikhil Kanhere, Felipe Morgado, et al.
Plos One|March 6, 2014
Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumoniaAnne Mehl, Peyman Ghorbani, David Douda, et al.
Mediators of Inflammation|September 2, 2014
Multitracer stable isotope quantification of arginase and nitric oxide synthase activity in a mouse model of pseudomonas lung infectionHartmut Grasemann, Thomas Jaecklin, Anne Mehl, et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2004
Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosisMatthias Griese, Robert Essl, Reinhold Schmidt, et al.
Annals of the American Thoracic Society|April 14, 2017
Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic FibrosisRanjani Somayaji, Sanja Stanojevic, D Elizabeth Tullis, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 2, 2025
Biomarkers associated with clinical response to cystic fibrosis pulmonary exacerbation treatment and adjuvant prednisone therapyBradley S Quon, Jasleen K Matta, Michelle Shaw, et al.
Annals of Internal Medicine|July 19, 2021
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic TelangiectasiaMarie E Faughnan, Johannes J Mager, Steven W Hetts, et al.
The European Respiratory Journal|October 12, 2019
Long-term effect of CFTR modulator therapy on airway nitric oxideHartmut Grasemann, Michelle Klingel, Julie Avolio, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 22, 2022
Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosisIsabel Gascon Casaredi, Michelle Shaw, Valerie Waters, et al.
Pageof 39